IMC Chicago’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$33.9M Buy
397,200
+175,800
+79% +$15.7M 0.01% 640
2025
Q4
$17.5M Buy
221,400
+22,100
+11% +$1.73M 0.01% 904
2025
Q3
$15.9M Sell
199,300
-5,300
-3% -$452K 0.01% 888
2025
Q2
$18.6M Buy
204,600
+57,300
+39% +$5.23M 0.01% 732
2025
Q1
$13.8M Sell
147,300
-28,600
-16% -$2.56M 0.01% 741
2024
Q4
$16M Sell
175,900
-8,500
-5% -$811K 0.01% 703
2024
Q3
$19.1M Sell
184,400
-74,300
-29% -$7.57M 0.01% 565
2024
Q2
$25.1M Buy
258,700
+141,600
+121% +$13.1M 0.02% 466
2024
Q1
$10.5M Buy
117,100
+45,300
+63% +$3.84M 0.01% 689
2023
Q4
$5.72M Buy
71,800
+26,600
+59% +$2M ﹤0.01% 838
2023
Q3
$3.21M Buy
+45,200
New +$3.38M ﹤0.01% 853

Other funds holding CL

IMC Chicago's CL Position: Q1 2026 in Review

IMC Chicago sold out of Colgate-Palmolive (CL) in Q1 2026, closing a stake of 39,978 shares — an estimated $3.56M sold.

IMC Chicago first reported a position in CL in Q3 2023 and held it in 7 quarters. The position peaked at $9.18M in Q3 2024. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • IMC Chicago reported no remaining Colgate-Palmolive position as of Q1 2026 after selling out during the quarter.
  • IMC Chicago sold 39,978 Colgate-Palmolive shares in Q1 2026, an estimated $3.56M.
  • IMC Chicago first reported a position in Colgate-Palmolive in Q3 2023 and held it in 7 quarters.
  • IMC Chicago's Colgate-Palmolive position peaked at $9.18M in Q3 2024.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.